Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Evidence-based Medicine Improves Outcomes of Anticoagulation Therapy in Patients With Atrial Fibrillation

NCT04774341 is registered in ClinicalTrials.gov with Center of Personalized Medicine, Pirogova as lead sponsor.

NCT NCT04774341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04774341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Evidence-based Medicine Improves Outcomes of Anticoagulation Therapy in Patients With Atrial Fibrillation
Lead sponsor
Center of Personalized Medicine, Pirogova
Phase
Observational
Overall status
Completed
Start date
January 10, 2021
Completion date
February 24, 2021
Enrollment
4,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adherence to personalized ebm anticoagulant treatment in patients at high risk for stroke